Insulin aspart, recombinant Subcutaneous and Nivestym Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Nivestym Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: filgrastim
Brand name: Neupogen, Neupogen SingleJect, Nivestym, Zarxio
Synonyms: Nivestym
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Nivolumab
- Insulin aspart, recombinant Subcutaneous-Nivolumab Intravenous
- Insulin aspart, recombinant Subcutaneous-Nizatidine
- Insulin aspart, recombinant Subcutaneous-Nizatidine Capsules and Tablets
- Insulin aspart, recombinant Subcutaneous-Nizatidine Oral Solution
- Insulin aspart, recombinant Subcutaneous-Nizatidine Solution
- Nivestym Injection-Insulin degludec
- Nivestym Injection-Insulin Degludec (U-100) Prefilled Pens
- Nivestym Injection-Insulin Degludec (U-100) Vials
- Nivestym Injection-Insulin Degludec (U-200) Prefilled Pens
- Nivestym Injection-Insulin degludec and liraglutide
- Nivestym Injection-Insulin degludec and liraglutide Subcutaneous